* Note: Prices are in Million (M) USD.
Description:
908 Devices Inc. (MASS) is a leading technology firm specializing in advanced measurement devices for chemical and biochemical analysis, driven by innovation in microfluidics and mass spectrometry. Headquartered in Boston, Massachusetts, the company offers cutting-edge instruments designed for a variety of sectors, including pharmaceuticals, biotechnology, and environmental monitoring. With a robust global presence across North America, Europe, the Middle East, Africa, and Asia Pacific, 908 Devices is well-positioned to address the growing demand for efficient analytical solutions, reinforcing its status as a key player in the analytical instrument industry.
These criteria used Company's Cash, EBITDA and Debt balance to determines its fair value:
Cash : $63 M
Debt : $0 M
EBITDA : $-37 M
Since Ebitda is less than 0, 0 points assigned.
This criteria used industry in which company operates:
Sector: Information technology
Industry: Medical devices
Based on industry, 3 points assigned.
This criteria used Company's Price To Earning (P/E) Ratio to determines its fair value:
Message: Cannot calculate PE Ratio since EPS is either 0 or negative.
Using default values for calculation.
Forward PE Ratio (using default values): 20.00
Since Forward PE Ratio is between 20 - 25, 2 points assigned.
This criteria used Company's ability to convert Sales into free cash flow to determine fair value:
Using last 7 overlapping fiscal years (max 20).Average Free Cash Flow: $-18 M
Average Revenue: $38 M
Revenue Converted To Free Cash Flow (%): -48.0%
Since Free Cash Flow (FCF) to Revenue percentage is non-positive, 0 point assigned.
This criteria used company's growth potential to calculate its fair value:
Latest Revenue (2024-12-31): $60 M
Revenue 5 Years Ago (2019-12-31): $18 M
Total Growth over 5 Years: 231.8%
5-Year Revenue CAGR (Historical): 27.1%
Forward 5-Year CAGR (Tapered): 13.6%
Since historical Revenue CAGR is greater than 20, 5 points assigned.
This criteria used Company's ability to buy back its own share:
Latest Share Count (2024-12-31): $34 M
Share Count 5 Years Ago (2020-12-31): $5 M
Company is not buying back its own shares, 0 points assigned.
This criteria used Company's dividend payout ratio to determine its fair value:
Next Year Earnings Per Share (EPS): $0.00
Trailing 12-Month Earnings Per Share (EPS): $0.00
Average Earnings Per Share (EPS): $0.00
Dividend Per Share (DPS): $0
Payout Ratio: 0%
Dividend Yield: 0.00%
Since Dividend Per Share is less than or equal to 0, 0 point assigned.
Since Dividend Yield is less than 1, 0 point assigned.
This criteria used Company's Return On Equity (ROE%) to determine its fair value:
Using last 5 valid ROE years (max 20).Average ROE: -24.2%
Since Average ROE is non-positive, 0 point assigned.
This criteria used Company's current price to its 52 week low price to determines its fair value:
Current Price: $5.38
52-Week Low: $1.81
Threshold Price (15% Above 52-Week Low): $2.08
Since Current price is not within 15% threshold, 0 point assigned.
This criteria used Company's Market Cap to determines its fair value:
Market Capitalization: $210 M
Since Market Cap is less than 10B, 1 point assigned.
% Exposure to Total Portfolio
Based on the market cap, we recommend do not exceed 0.5% exposure of Total Portfolio.
Warren Buffett's Owners' Earnings:
Owners' Earnings (FCF/Share, latest positive annual) (2020-12-31): $0.12
Note: Many fast-growing companies reinvest heavily, so Owners' Earnings may appear low.
Consider other factors in your valuation.
Value-Trade has assigned 11 points to above 908 Devices Inc (MASS) stock.
Fair Value PE 12, Industry Based PE 18, Growth Based PE 15, Risk-Free Anchored PE (25% MoS) 18.47. Based on these 4 values, average assigned is 15.87. The fair value of 908 Devices Inc (MASS) stock cannot be calculated since EBITDA and EPS are either 0 or negative.
